CC
GILD icon

Curian Capital’s Gilead Sciences GILD Stock Holding History

Curian Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-51,336
Closed -$5.2M – 159
2015
Q4 		$5.2M Sell
51,336
-94,860
-65% -$9.87M 0.38% 46
2015
Q3 		$14.4M Buy
146,196
+77,525
+113% +$8.61M 0.38% 51
2015
Q2 		$8.04M Buy
68,671
+61,194
+818% +$6.69M 0.14% 194
2015
Q1 		$734K Sell
7,477
-1,297
-15% -$132K 0.01% 529
2014
Q4 		$827K Sell
8,774
-48,780
-85% -$5.05M 0.01% 486
2014
Q3 		$6.13M Sell
57,554
-43,185
-43% -$4.23M 0.11% 210
2014
Q2 		$8.35M Sell
100,739
-92,558
-48% -$7.2M 0.15% 173
2014
Q1 		$13.7M Sell
193,297
-131,868
-41% -$10.3M 0.24% 90
2013
Q4 		$24.4M Sell
325,165
-119,980
-27% -$8.35M 0.43% 45
2013
Q3 		$28M Buy
445,145
+2,619
+0.6% +$157K 0.5% 37
2013
Q2 		$22.7M Buy
+442,526
New +$23.1M 0.41% 42

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Curian Capital's GILD Position: Q1 2016 in Review

Curian Capital sold out of Gilead Sciences (GILD) in Q1 2016, closing a stake of 51,336 shares — an estimated $5.2M sold.

Curian Capital first reported a position in GILD in Q2 2013 and held it in 11 quarters. The position peaked at $28M in Q3 2013. 1,629 funds tracked by Wall St. Rank hold GILD as of Q1 2016.

  • Curian Capital reported no remaining Gilead Sciences position as of Q1 2016 after selling out during the quarter.
  • Curian Capital sold 51,336 Gilead Sciences shares in Q1 2016, an estimated $5.2M.
  • Curian Capital first reported a position in Gilead Sciences in Q2 2013 and held it in 11 quarters.
  • Curian Capital's Gilead Sciences position peaked at $28M in Q3 2013.
  • 1,629 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2016.

Based on Curian Capital's 13F filing for Q1 2016.